关于α5尼古丁乙胆受体在肺癌进展中的前景
Jiaying Cai1, Jingting Wang1, Zengping Wang1
1Research Center of Basic Medicine, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Frontiers in cell and developmental biology
|March 27, 2025
概括
阿尔法5尼古丁性乙胆受体 (α5-nAChR) 在肺癌进展和免疫反应中起着关键作用. 向α5-nAChR可能为肺癌治疗和免疫治疗提供新的策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 尼古丁乙胆受体 (nAChRs) 对于各种细胞类型的生理调节至关重要.
- 由CHRNA5编码的α5尼古丁乙胆受体 (α5-nAChR) 与肺癌的发展和免疫调节有关.
- α5-nAChR通过像STAT3这样的信号通路影响肺癌的进展,并通过相关因素影响免疫反应.
研究的目的:
- 审查α5-nAChR在肺癌进展中的作用.
- 探索向α5-nAChR用于肺癌新型治疗策略的潜力.
主要方法:
- 对肺癌中α5-nAChR研究的文献综述.
- 分析受α5-nAChR影响的信号通路和免疫因子.
主要成果:
- α5-nAChR是肺癌发展的重要媒介.
- α5-nAChR通过各种途径调节肺部免疫反应.
- 有证据表明α5-nAChR参与了肺癌中STAT3信号传递.
结论:
- 向α5-nAChR为开发新的抗癌疗法提供了一个有希望的途径.
- α5-nAChR调节可以增强对肺癌的免疫反应.
- 对α5-nAChR的进一步研究对于创新的肺癌治疗策略是有必要的.
相关概念视频
Cholinergic Receptors: Nicotinic
2.1K
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
2.1K
Cholinergic Receptors: Muscarinic
1.6K
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
1.6K
Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Direct-Acting Cholinergic Agonists: Therapeutic Uses
654
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
654
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
817
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
817


